'There and back again': Revisiting the pathophysiological roles of human endogenous retroviruses in the post-genomic era

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1626, 2013, Pages

  Magiorkinis, Gkikas ^a   Belshaw, Robert ^b   Katzourakis, Aris ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Endogenous retroviruses; HERV K; Pathogenesis; Pathophysiology

Indexed keywords

BIOINFORMATICS; BIOTECHNOLOGY; CANCER; GENOMICS; PATHOGENICITY; PATHOLOGY; PUBLIC HEALTH; RECONSTRUCTION; VIRUS;

TRANSPOSON;

CLASSIFICATION; ENDOGENOUS RETROVIRUS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HUMAN GENOME; MUTATION; NEOPLASM; TRANSPOSON; VIROLOGY;

DNA TRANSPOSABLE ELEMENTS; ENDOGENOUS RETROVIRUSES; GENE EXPRESSION REGULATION, VIRAL; GENOME, HUMAN; HUMANS; MUTATION; NEOPLASMS;

EID: 84881595452     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0504     Document Type: Article

References (159)

1. Jern P, Coffin JM. 2008 Effects of retroviruses on host genome function. Annu. Rev. Genet. 42, 709-732. (doi:10.1146/annurev.genet.42.110807.091501)
2. Boeke JD, Stoye JP. 1997 Retrotransposons, endogenous retroviruses, and the evolution of retroelements. In Retroviruses (eds JM Coffin, SH Hughes, HE Varmus), pp. 343-436. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
3. Lander ES et al. 2001 Initial sequencing and analysis of the human genome. Nature 409, 860-921. (doi:10.1038/35057062)
4. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012 An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65. (doi:10.1038/nature11632)
5. Ioannidis JP. 2005 Why most published research findings are false. PLoS Med. 2, e124. (doi:10.1371/ journal.pmed.0020124)
6. Ioannidis JP. 2008 Why most discovered true associations are inflated. Epidemiology 19, 640-648. (doi:10.1097/EDE.0b013e31818131e7)
7. Stocking C, Kozak CA. 2008 Murine endogenous retroviruses. Cell Mol. Life Sci. 65, 3383-3398. (doi:10.1007/s00018-008-8497-0)
8. Tristem M. 2000 Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J. Virol. 74, 3715-3730. (doi:10.1128/JVI.74.8.3715-3730.2000)
9. Jern P, Sperber GO, Blomberg J. 2004 Definition and variation of human endogenous retrovirus H. Virology 327, 93-110. (doi:10.1016/j.virol. 2004.06.023)
10. Bannert N, Kurth R. 2006 The evolutionary dynamics of human endogenous retroviral families. Annu. Rev. Genomics Hum. Genet. 7, 149-173. (doi:10.1146/annurev.genom.7.080505.115700)
11. Katzourakis A, Tristem M. 2005 Phylogeny of human endogenous and exogenous retroviruses. In Retroviruses and primate genome evolution (ed. ED Sverdlov), pp. 186-203. Austin, TX: Landes Bioscience.
12. Belshaw R, Katzourakis A, Paces J, Burt A, Tristem M. 2005 High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol. Biol. Evol. 22, 814-817. (doi:10.1093/molbev/msi088)
13. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, Tristem M. 2004 Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl Acad. Sci. USA 101, 4894-4899. (doi:10. 1073/pnas.0307800101)
14. Katzourakis A, Rambaut A, Pybus OG. 2005 The evolutionary dynamics of endogenous retroviruses. Trends Microbiol. 13, 463-468. (doi:10.1016/j.tim. 2005.08.004)
15. Benit L, Lallemand JB, Casella JF, Philippe H, Heidmann T. 1999 ERV-L elements: a family of endogenous retrovirus-like elements active throughout the evolution of mammals. J. Virol. 73, 3301-3308.
16. Anderssen S, Sjottem E, Svineng G, Johansen T. 1997 Comparative analyses of LTRs of the ERV-H family of primate-specific retrovirus-like elements isolated from marmoset, African green monkey, and man. Virology 234, 14-30. (doi:10.1006/viro. 1997.8590)
17. Mager DL, Freeman JD. 1995 HERV-H endogenous retroviruses: presence in the New World branch but amplification in the Old World primate lineage. Virology 213, 395-404. (doi:10.1006/viro. 1995.0012)
18. de Parseval N, Casella J, Gressin L, Heidmann T. 2001 Characterization of the three HERV-H proviruses with an open envelope reading frame encompassing the immunosuppressive domain and evolutionary history in primates. Virology 279, 558-569. (doi:10.1006/viro.2000.0737)
19. Mangeney M, de Parseval N, Thomas G, Heidmann T. 2001 The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J. Gen. Virol. 82, 2515-2518.
20. Goodchild NL, Freeman JD, Mager DL. 1995 Spliced HERV-H endogenous retroviral sequences in human genomic DNA: evidence for amplification via retrotransposition. Virology 206, 164-173. (doi:10. 1016/S0042-6822(95)80031-X)
21. Kim HS, Takenaka O, Crow TJ. 1999 Isolation and phylogeny of endogenous retrovirus sequences belonging to the HERV-W family in primates. J. Gen. Virol. 80, 2613-2619.
22. Costas J. 2002 Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W. Mol. Biol. Evol. 19, 526-533. (doi:10. 1093/oxfordjournals.molbev.a004108)
23. Mi S et al. 2000 Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403, 785-789. (doi:10. 1038/35001608)
24. Blaise S, de Parseval N, Benit L, Heidmann T. 2003 Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc. Natl Acad. Sci. USA 100, 13013-13018. (doi:10.1073/ pnas.2132646100)
25. Pavlicek A, Paces J, Elleder D, Hejnar J. 2002 Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution. Genome Res. 12, 391-399. (doi:10.1101/gr.216902).
26. Subramanian RP, Wildschutte JH, Russo C, Coffin JM. 2011 Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8, 90. (doi:10.1186/1742-4690-8-90)
27. Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK, Lenz J. 1999 Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr. Biol. 9, 861-868. (doi:10.1016/ S0960-9822(99)80390-X)
28. Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M. 2005 Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J. Virol. 79, 12507-12514. (doi:10.1128/JVI.79.19. 12507-12514.2005)
29. Hughes JF, Coffin JM. 2004 Human endogenous retrovirus K solo-LTR formation and insertional polymorphisms: implications for human and viral evolution. Proc. Natl Acad. Sci. USA 101, 1668-1672. (doi:10.1073/pnas.0307885100)
30. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. 2001 Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11, 1531-1535. (doi:10.1016/S0960-9822(01)00455-9)
31. Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, Heidmann T. 2006 Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16, 1548-1556. (doi:10.1101/gr.5565706)
32. Lee YN, Bieniasz PD. 2007 Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3, e10. (doi:10.1371/journal.ppat.0030010)
33. Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, Meese E. 1999 An almost-intact human endogenous retrovirus K on human chromosome 7. Nat. Genet. 21, 257-258. (doi:10.1038/6766)
34. Ono M, Yasunaga T, Miyata T, Ushikubo H. 1986 Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J. Virol. 60, 589-598.
35. Ono M. 1986 Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J. Virol. 58, 937-944.
36. Blaise S, de Parseval N, Heidmann T. 2005 Functional characterization of two newly identified human endogenous retrovirus coding envelope genes. Retrovirology 2, 19. (doi:10.1186/1742-4690-2-19)
37. Leung DC, Lorincz MC. 2012 Silencing of endogenous retroviruses: when and why do histone marks predominate? Trends Biochem. Sci. 37, 127-133. (doi:10.1016/j.tibs.2011.11.006)
38. Rowe HM, Trono D. 2011 Dynamic control of endogenous retroviruses during development. Virology 411, 273-287. (doi:10.1016/j.virol.2010. 12.007)
39. Armitage AE et al. 2008 Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences. J. Virol. 82, 8743-8761. (doi:10.1128/JVI.00584-08)
40. Goila-Gaur R, Strebel K. 2008 HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5, 51. (doi:10. 1186/1742-4690-5-51)
41. Chuma S, Pillai RS. 2009 Retrotransposon silencing by piRNAs: ping-pong players mark their sub-cellular boundaries. PLoS Genet. 5, e1000770. (doi:10.1371/journal.pgen.1000770)
42. Phalke S, Nickel O, Walluscheck D, Hortig F, Onorati MC, Reuter G. 2009 Retrotransposon silencing and telomere integrity in somatic cells of Drosophila depends on the cytosine-5 methyltransferase DNMT2. Nat. Genet. 41, 696-702. (doi:10.1038/ ng.360)
43. Suzuki S et al. 2007 Retrotransposon silencing by DNA methylation can drive mammalian genomic imprinting. PLoS Genet. 3, e55. (doi:10.1371/ journal.pgen.0030055)
44. Barbot W, Dupressoir A, Lazar V, Heidmann T. 2002 Epigenetic regulation of an IAP retrotransposon in the aging mouse: progressive demethylation and de-silencing of the element by its repetitive induction. Nucleic Acids Res. 30, 2365-2373. (doi:10.1093/nar/30.11.2365)
45. Rous P. 1911 A sarcoma of the FOWL transmissible by an agent separable from the tumor cells. J. Exp. Med. 13, 397-411. (doi:10.1084/jem.13.4.397)
46. Weiss RA, Vogt PK. 2011 100 years of Rous sarcoma virus. J. Exp. Med. 208, 2351-2355. (doi:10.1084/ jem.20112160)
47. Voisset C, Weiss RA, Griffiths DJ. 2008 Human RNA 'rumor' viruses: the search for novel human retroviruses in chronic disease. Microbiol. Mol. Biol. Rev. 72, 157-196. (doi:10.1128/MMBR.00033-07)
48. Magiorkinis G, Gifford RJ, Katzourakis A, De Ranter J, Belshaw R. 2012 Env-less endogenous retroviruses are genomic superspreaders. Proc. Natl Acad. Sci. USA 109, 7385-7390. (doi:10.1073/pnas. 1200913109)
49. Ewing AD, Kazazian Jr HH. 2010 High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res. 20, 1262-1270. (doi:10.1101/gr. 106419.110)
50. Baillie JK et al. 2011 Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479, 534-537. (doi:10.1038/nature10531)
51. Coufal NG et al. 2009 L1 retrotransposition in human neural progenitor cells. Nature 460, 1127-1131. (doi:10.1038/nature08248)
52. Evrony GD et al. 2012 Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell 151, 483-496. (doi:10.1016/j.cell.2012.09.035)
53. Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir EG, Vertino PM, Devine SE. 2010 Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141, 1253-1261. (doi:10.1016/j.cell.2010.05.020)
54. Feschotte C, Gilbert C. 2012 Endogenous viruses: insights into viral evolution and impact on host biology. Nat. Rev. Genet. 13, 283-296. (doi:10. 1038/nrg3199)
55. Hughes JF, Coffin JM. 2001 Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat. Genet. 29, 487-489. (doi:10.1038/ng775)
56. Lebedev YB, Belonovitch OS, Zybrova NV, Khil PP, Kurdyukov SG, Vinogradova TV, Hunsmann G, Sverdlov ED. 2000 Differences in HERV-K LTR insertions in orthologous loci of humans and great apes. Gene 247, 265-277. (doi:10.1016/S0378-1119(00)00062-7)
57. Dangel AW, Baker BJ, Mendoza AR, Yu CY. 1995 Complement component C4 gene intron 9 as a phylogenetic marker for primates: long terminal repeats of the endogenous retrovirus ERV-K(C4) are a molecular clock of evolution. Immunogenetics 42, 41-52. (doi:10.1007/BF00164986)
58. Jha AR, Nixon DF, Rosenberg MG, Martin JN, Deeks SG, Hudson RR, Garrison KE, Pillai SK. 2011 Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans. PLoS ONE 6, e20234. (doi:10. 1371/journal.pone.0020234)
59. Jha AR et al. 2009 Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens. Mol. Biol. Evol. 26, 2617-2626. (doi:10. 1093/molbev/msp180)
60. Agoni L, Golden A, Guha C, Lenz J. 2012 Neandertal and Denisovan retroviruses. Curr. Biol. 22, R437-R438. (doi:10.1016/j.cub.2012.04.049)
61. Barbulescu M, Turner G, Su M, Kim R, Jensen-Seaman MI, Deinard AS, Kidd KK, Lenz J. 2001 A HERV-K provirus in chimpanzees, bonobos and gorillas, but not humans. Curr. Biol. 11, 779-783. (doi:10.1016/S0960-9822(01)00227-5)
62. Anon. 2010 E pluribus unum. Nat. Methods 7, 331. (doi:10.1038/nmeth0510-331)
63. Kidd JM et al. 2010 A human genome structural variation sequencing resource reveals insights into mutational mechanisms. Cell 143, 837-847. (doi:10.1016/j.cell.2010.10.027)
64. Tarlinton RE, Meers J, Young PR. 2006 Retroviral invasion of the koala genome. Nature 442, 79-81. (doi:10.1038/nature04841)
65. Williams GC. 1957 Pleiotropy, natural selection and the evolution of senescence. Evol. Int. J. Org. Evol. 11, 398-411. (doi:10.2307/2406060)
66. Hirsch HR. 1980 Evolution of senescence: influence of age-dependent death rates on the natural increase of a hypothetical population. J. Theor. Biol. 86, 149-168. (doi:10.1016/0022-5193(80)90072-7)
67. Gould KG, Flint M, Graham CE. 1981 Chimpanzee reproductive senescence: a possible model for evolution of the menopause. Maturitas 3, 157-166. (doi:10.1016/0378-5122(81)90007-4)
68. Hirsch HR. 1982 Evolution of senescence: natural increase of populations displaying Gompertz-or power-law death rates and constant or age-dependent maternity rates. J. Theor. Biol. 98, 321-346. (doi:10.1016/0022-5193(82)90268-5)
69. Mueller LD. 1987 Evolution of accelerated senescence in laboratory populations of Drosophila. Proc. Natl Acad. Sci. USA 84, 1974-1977. (doi:10. 1073/pnas.84.7.1974)
70. Kirkwood TB, Rose MR. 1991 Evolution of senescence: late survival sacrificed for reproduction. Phil. Trans. R. Soc. Lond. B 332, 15-24. (doi:10. 1098/rstb.1991.0028)
71. Bell G. 1993 Pathogen evolution within host individuals as a primary cause of senescence. Genetica 91, 21-34. (doi:10.1007/ BF01435985)
72. Charlesworth B, Hughes KA. 1996 Age-specific inbreeding depression and components of genetic variance in relation to the evolution of senescence. Proc. Natl Acad. Sci. USA 93, 6140-6145. (doi:10. 1073/pnas.93.12.6140)
73. Gagos S, Iliopoulos D, Tseleni-Balafouta S, Agapitos M, Antachopoulos C, Kostakis A, Karayannakos P, Skalkeas G. 1996 Cell senescence and a mechanism of clonal evolution leading to continuous cell proliferation, loss of heterozygosity, and tumor heterogeneity: studies on two immortal colon cancer cell lines. Cancer Genet. Cytogenet. 90, 157-165. (doi:10.1016/S0165-4608(96)00049-0)
74. Burstein M. 1998 Evolution and the senescence process. Broadening our view of aging. J. Gerontol. Nurs. 24, 16-19.
75. Caldwell ME, Denicola GM, Martins CP, Jacobetz MA, Maitra A, Hruban RH, Tuveson DA. 2011 Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene 31, 1599-1608. (doi:10.1038/onc. 2011.350)
76. Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, Kurth R. 1993 Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc. Natl Acad. Sci. USA 90, 4480-4484. (doi:10.1073/pnas.90.10.4480)
77. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J. 2011 Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2, 180. (doi:10. 1038/ncomms1180)
78. Ono M, Kawakami M, Ushikubo H. 1987 Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J. Virol. 61, 2059-2062.
79. Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, Strong TV. 2001 Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin. Cancer Res. 7, 1553-1560.
80. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL. 2003 Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22, 1528-1535. (doi:10.1038/sj. onc.1206241)
81. Buscher K et al. 2006 Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res. 16, 223-234. (doi:10. 1097/01.cmr.0000215031.07941.ca)
82. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. 2006 Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses 22, 979-984. (doi:10.1089/aid.2006.22.979)
83. Contreras-Galindo R, Lopez P, Velez R, Yamamura Y. 2007 HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res. Hum. Retroviruses 23, 116-122. (doi:10.1089/aid.2006.0117)
84. Wang-Johanning F et al. 2007 Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int. J. Cancer 120, 81-90. (doi:10.1002/ijc.22256)
85. Contreras-Galindo R et al. 2008 Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J. Virol. 82, 9329-9336. (doi:10.1128/JVI.00646-08)
86. Frank O, Verbeke C, Schwarz N, Mayer J, Fabarius A, Hehlmann R, Leib-Mosch C, Seifarth W. 2008 Variable transcriptional activity of endogenous retroviruses in human breast cancer. J. Virol. 82, 1808-1818. (doi:10.1128/JVI.02115-07)
87. Contreras-Galindo RA et al. 2011 Characterization of human endogenous retroviral elements in the blood of HIV-1-Infected individuals. J. Virol. 86, 262-276. (doi:10.1128/JVI.00602-11)
88. SenGupta D et al. 2011 Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection. J. Virol. 85, 6977-6985. (doi:10.1128/JVI.00179-11)
89. Rakoff-Nahoum S et al. 2006 Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS Res. Hum. Retroviruses 22, 52-56. (doi:10. 1089/aid.2006.22.52)
90. Tandon R et al. 2011 Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects. J. Virol. 85, 11526-11531. (doi:10.1128/JVI.05418-11)
91. Garrison KE et al. 2007 T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog. 3, e165. (doi:10.1371/journal.ppat.0030165)
92. Hahn S, Ugurel S, Hanschmann KM, Strobel H, Tondera C, Schadendorf D, Lower J, Lower R. 2008 Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res. Hum. Retroviruses 24, 717-723. (doi:10.1089/aid.2007.0286)
93. Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. 1997 Characterization of the antibody response specific for the human endogenous retrovirus HTDV/ HERV-K. J. Virol. 71, 4581-4588.
94. Dewannieux M, Blaise S, Heidmann T. 2005 Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J. Virol. 79, 15573-15577. (doi:10. 1128/JVI.79.24.15573-15577.2005)
95. Paprotka T et al. 2011 Recombinant origin of the retrovirus XMRV. Science 333, 97-101. (doi:10. 1126/science.1205292)
96. Young GR, Eksmond U, Salcedo R, Alexopoulou L, Stoye JP, Kassiotis G. 2012 Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 491, 774-778. (doi:10.1038/ nature11599)
97. Stoye JP. 2001 Endogenous retroviruses: still active after all these years? Curr. Biol. 11, R914-R916. (doi:10.1016/S0960-9822(01)00553-X)
98. Armbruester V, Sauter M, Krautkraemer E, Meese E, Kleiman A, Best B, Roemer K, Mueller-Lantzsch N. 2002 A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin. Cancer Res. 8, 1800-1807.
99. Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K, Mueller-Lantzsch N. 2005 Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 24, 3223-3228. (doi:10.1038/sj.onc. 1208543)
100. Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, Kremmer E, Roemer K, Mueller-Lantzsch N. 2000 Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 19, 4328-4336. (doi:10.1038/sj.onc. 1203794)
101. Denner J, Wunderlich V, Bierwolf D. 1986 Suppression of human lymphocyte mitogen response by proteins of the type-D retrovirus PMFV. Int. J. Cancer 37, 311-316. (doi:10.1002/ijc. 2910370221)
102. Mathes LE, Olsen RG, Hebebrand LC, Hoover EA, Schaller JP. 1978 Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature 274, 687-689. (doi:10.1038/ 274687a0)
103. Mathes LE, Olsen RG, Hebebrand LC, Hoover EA, Schaller JP, Adams PW, Nichols WS. 1979 Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res. 39, 950-955.
104. Mangeney M, Heidmann T. 1998 Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc. Natl Acad. Sci. USA 95, 14920-14925. (doi:10.1073/pnas.95.25. 14920)
105. Denner J. 2010 Immunosuppressive properties of endogenous retroviruses. In Retroviruses: molecular biology, genomics and pathogenesis (eds K Reinhard, N Bannert), pp. 41-45. Norfolk, UK: Caister Academic Press.
106. Rosenberg N, Jolicoeur P. 1997 Retroviral pathogenesis: oncogenesis. In Retroviruses (eds JM Coffin, SH Hughes, HE Varmus), pp. 475-586. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
107. Lamprecht B et al. 2010 Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat. Med. 16, 571-579. (doi:10.1038/nm.2129)
108. Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. 2009 Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15, 195-206. (doi:10.1016/ j.ccr.2009.01.023).
109. DeGregori J. 2011 Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res. 71, 3739-3744. (doi:10.1158/0008-5472.CAN-11-0342)
110. Billaud M, Santoro M. 2011 Is co-option a prevailing mechanism during cancer progression? Cancer Res. 71, 6572-6575. (doi:10.1158/0008-5472.CAN-11-2158)
111. Gatenby RA, Gillies RJ. 2008 A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 8, 56-61. (doi:10.1038/nrc2255)
112. Feschotte C. 2008 Transposable elements and the evolution of regulatory networks. Nat. Rev. Genet 9, 397-405. (doi:10.1038/nrg2337)
113. Berthoux L, Sebastian S, Sokolskaja E, Luban J. 2005 Cyclophilin A is required for TRIM5fag-mediated resistance to HIV-1 in Old World monkey cells. Proc. Natl Acad. Sci. USA 102, 14849-14853. (doi:10. 1073/pnas.0505659102)
114. Nisole S, Lynch C, Stoye JP, Yap MW. 2004 A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc. Natl Acad. Sci. USA 101, 13324-13328. (doi:10.1073/pnas. 0404640101)
115. Sayah DM, Sokolskaja E, Berthoux L, Luban J. 2004 Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573. (doi:10.1038/nature02777)
116. Sato A et al. 2010 Association of RNase L with a Ras GTPase-activating-like protein IQGAP1 in mediating the apoptosis of a human cancer cell-line. FEBS J. 277, 4464-4473. (doi:10.1111/j.1742-4658.2010. 07833.x)
117. Silverman RH. 2003 Implications for RNase L in prostate cancer biology. Biochemistry 42, 1805-1812. (doi:10.1021/bi027147i)
118. Lower R. 1999 The pathogenic potential of endogenous retroviruses: facts and fantasies. Trends Microbiol. 7, 350-356. (doi:10.1016/S0966-842X(99)01565-6)
119. Herve CA, Lugli EB, Brand A, Griffiths DJ, Venables PJ. 2002 Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin. Exp. Immunol. 128, 75-82. (doi:10.1046/j.1365-2249. 2002.01735.x)
120. Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA. 2010 Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328, 749-752. (doi:10. 1126/science.1185837)
121. Belshaw R, Watson J, Katzourakis A, Howe A, Woolven-Allen J, Burt A, Tristem M. 2007 Rate of recombinational deletion among human endogenous retroviruses. J. Virol. 81, 9437-9442. (doi:10.1128/JVI.02216-06)
122. Ostertag EM, Goodier JL, Zhang Y, Kazazian Jr HH. 2003 SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 73, 1444-1451. (doi:10.1086/ 380207)
123. Amanuma H, Katori A, Obata M, Sagata N, Ikawa Y. 1983 Complete nucleotide sequence of the gene for the specific glycoprotein (gp55) of Friend spleen focus-forming virus. Proc. Natl Acad. Sci. USA 80, 3913-3917. (doi:10.1073/pnas.80.13.3913)
124. Wolff L, Ruscetti S. 1988 The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia. J. Virol. 62, 2158-2163.
125. Aswad A, Katzourakis A. 2012 Paleovirology and virally derived immunity. Trends Ecol. Evol. 27, 627-636
126. Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, Richaud A, Ducos B, Heidmann T. 2007 Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc. Natl Acad. Sci. USA 104, 20534-20539. (doi:10.1073/pnas.0707873105)
127. Murchison EP et al. 2012 Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell 148, 780-791. (doi:10.1016/j.cell.2011. 11.065)
128. Murchison EP et al. 2010 The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science 327, 84-87. (doi:10.1126/science.1180616)
129. Murchison EP. 2008 Clonally transmissible cancers in dogs and Tasmanian devils. Oncogene 27(Suppl. 2), S19-S30. (doi:10.1038/onc.2009.350)
130. Strauss DC, Thomas JM. 2010 Transmission of donor melanoma by organ transplantation. Lancet Oncol. II, 790-796. (doi:10.1016/S1470-2045(10)70024-3)
131. Warrens AN et al. 2012 Advising potential recipients on the use of organs from donors with primary central nervous system tumors. Transplantation 93, 348-353. (doi:10.1097/TP.0b013e31823f7f47).
132. Hoffner L, Surti U. 2012 The genetics of gestational trophoblastic disease: a rare complication of pregnancy. Cancer Genet. 205, 63-77. (doi:10. 1016/j.cancergen.2012.01.004)
133. Wang X, Fu S, Freedman RS, Liu J, Kavanagh JJ. 2006 Immunobiology of gestational trophoblastic diseases. Int. J. Gynecol. Cancer 16, 1500-1515. (doi:10.1111/j.1525-1438.2006.00539.x)
134. Brinsden PR. 2003 Gestational surrogacy. Hum. Reprod. Update 9, 483-491. (doi:10.1093/humupd/ dmg033)
135. Dupressoir A, Lavialle C, Heidmann T. 2012 From ancestral infectious retroviruses to bona fide cellular genes: role of the captured syncytins in placentation. Placenta 33, 663-671. (doi:10.1016/j. placenta.2012.05.005)
136. Gayer G. 2012 Images in clinical medicine. Abdominal ectopic pregnancy. N. Engl. J. Med. 367, 2334. (doi:10.1056/NEJMicm1111814)
137. Poole A, Haas D, Magann EF. 2012 Early abdominal ectopic pregnancies: a systematic review of the literature. Gynecol. Obstet. Invest. 74, 249-260. (doi:10.1159/000342997)
138. Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA. 2012 Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst. Rev. 12, CD008891. (doi:10. 1002/14651858.CD008891.pub2)
139. Cornelis G, Heidmann O, Bernard-Stoecklin S, Reynaud K, Veron G, Mulot B, Dupressoir A, Heidmann T. 2012 Ancestral capture of syncytin-Car1, a fusogenic endogenous retroviral envelope gene involved in placentation and conserved in Carnivora. Proc. Natl Acad. Sci. USA 109, E432-E441. (doi:10.1073/pnas.1115346109)
140. Dupressoir A, Marceau G, Vernochet C, Benit L, Kanellopoulos C, Sapin V, Heidmann T. 2005 Syncytin-A and syncytin-B, two fusogenic placenta-specific murine envelope genes of retroviral origin conserved in Muridae. Proc. Natl Acad. Sci. USA 102, 725-730. (doi:10.1073/pnas.0406509102)
141. Heidmann O, Vernochet C, Dupressoir A, Heidmann T. 2009 Identification of an endogenous retroviral envelope gene with fusogenic activity and placenta-specific expression in the rabbit: a new "syncytin" in a third order of mammals. Retrovirology 6, 107. (doi:10.1186/1742-4690-6-107)
142. Kwak-Kim J. 2012 Clinical reproductive immunology in critical demand. Am. J. Reprod. Immunol. 67, 267. (doi:10.1111/j.1600-0897.2012. 01125.x)
143. Coulam CB, Acacio B. 2012 Does immunotherapy for treatment of reproductive failure enhance live births? Am. J. Reprod. Immunol. 67, 296-304. (doi:10.1111/j.1600-0897.2012.01111.x)
144. Bansal AS, Bajardeen B, Thum MY. 2012 The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J. Reprod. Immunol. 93, 41-51. (doi:10.1016/j.jri. 2011.10.002)
145. Tang AW, Alfirevic Z, Quenby S. 2011 Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum. Reprod. 26, 1971-1980. (doi:10. 1093/humrep/der164)
146. Brown GK, Kreiss A, Lyons AB, Woods GM. 2011 Natural killer cell mediated cytotoxic responses in the Tasmanian devil. PLoS ONE 6, e24475. (doi:10. 1371/journal.pone.0024475)
147. Moyes D, Griffiths DJ, Venables PJ. 2007 Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet. 23, 326-333. (doi:10.1016/j.tig.2007.05.004)
148. Christensen T. 2005 Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev. Med. Virol. 15, 179-211. (doi:10.1002/rmv.465)
149. Baudino L, Yoshinobu K, Morito N, Santiago-Raber ML, Izui S. 2010 Role of endogenous retroviruses in murine SLE. Autoimmun. Rev. 10, 27-34. (doi:10. 1016/j.autrev.2010.07.012)
150. Balada E, Vilardell-Tarres M, Ordi-Ros J. 2010 Implication of human endogenous retroviruses in the development of autoimmune diseases. Int. Rev. Immunol. 29, 351-370. (doi:10.3109/08830185. 2010.485333)
151. Blank M, Shoenfeld Y, Perl A. 2009 Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus. Lupus 18, 1136-1143. (doi:10.1177/0961203309345728)
152. Stauffer Y, Marguerat S, Meylan F, Ucla C, Sutkowski N, Huber B, Pelet T, Conrad B. 2001 Interferon-alpha-induced endogenous superantigen. A model linking environment and autoimmunity. Immunity 15, 591-601. (doi:10.1016/S1074-7613(01)00212-6)
153. Ruprecht K, Gronen F, Sauter M, Best B, Rieckmann P, Mueller-Lantzsch N. 2008 Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis. J. Neurovirol. 14, 143-151. (doi:10.1080/13550280801958922)
154. Wiik AS. 2005 Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand. J. Rheumatol. 34, 260-268. (doi:10.1080/03009740500202664)
155. Satoh M et al. 2012 Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum. 64, 2319-2327. (doi:10.1002/art.34380)
156. Villesen P, Aagaard L, Wiuf C, Pedersen FS. 2004 Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1, 32. (doi:10.1186/1742-4690-1-32)
157. Cornelis G et al. 2013 Captured retroviral envelope syncytin gene associated with the unique placental structure of higher ruminants. Proc. Natl Acad. Sci. USA 110, E828-E837. (doi:10.1073/pnas. 1215787110)
158. Lavialle C, Cornelis G, Dupressoir A, Esnault C, Heidmann O, Vernochet C, Heidmann T. 2013 Paleovirology of 'syncytins', retroviral env genes exapted for a role in placentation. Phil. Trans. R. Soc. B 368, 20120507. (doi:10.1098/rstb. 2012.0507)
159. Duggal NK, Emerman M. 2012 Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 12, 687-695. (doi:10.1038/nri3295)